Related Experiment Video
Updated: Jan 5, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
Drug Tolerant Cells: An Emerging Target With Unique Transcriptomic Features
Divya Niveditha1, Harshita Sharma1, Anirudha Sahu1
1Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Pilani, India.
Abstract:
Long-term outcome of cancer therapy is often severely perturbed by the acquisition of drug resistance. Recent evidence point toward the survival of a subpopulation of tumor cells under acute drug stress that over time can re-populate the tumor. These transiently existing, weakly proliferative, drug-tolerant cells facilitate tumor cell survival until more stable resistance mechanisms are acquired. From a therapeutic perspective, understanding the molecular features of the tolerant cells is critical to attenuation of resistance. In this article, we discuss the transcriptomic features of drug-tolerant osteosarcoma cells that survive a high dose of cisplatin shock. We present the unique transcriptome of the minimally dividing tolerant cells in comparison with the proliferative persisters or resistant cells derived from the tolerant cells. Targeting the tolerant cells can represent an efficient therapeutic strategy impeding tumor recurrence.
Insights
Drug-tolerant cancer cells survive chemotherapy, potentially leading to resistance and recurrence. Understanding their unique gene expression is key to developing new treatments that target these cells and prevent tumor regrowth.
Area of Science:
- Oncology
- Cancer Biology
- Molecular Medicine
Background:
- Cancer therapy outcomes are often compromised by acquired drug resistance.
- A subpopulation of tumor cells can survive intense drug treatment, contributing to long-term resistance.
- These drug-tolerant cells are crucial for tumor cell survival and eventual resistance acquisition.
Purpose of the Study:
- To investigate the transcriptomic characteristics of drug-tolerant osteosarcoma cells.
- To compare the gene expression profiles of minimally dividing tolerant cells with proliferative persisters and resistant cells.
- To identify potential therapeutic targets within drug-tolerant cells to prevent tumor recurrence.
Main Methods:
- Analysis of the transcriptome of osteosarcoma cells surviving high-dose cisplatin treatment.
- Comparative transcriptomic analysis between drug-tolerant cells, proliferative persisters, and derived resistant cells.
Main Results:
- Identification of a unique transcriptome specific to drug-tolerant osteosarcoma cells.
- Characterization of the molecular features distinguishing tolerant cells from more proliferative or resistant populations.
- Demonstration that drug-tolerant cells exhibit minimal proliferation.
Conclusions:
- Drug-tolerant cells possess distinct transcriptomic profiles that differ from resistant or sensitive cells.
- Targeting these specific molecular features of tolerant cells offers a promising strategy to impede tumor recurrence.
- Understanding drug tolerance mechanisms is critical for improving long-term cancer therapy efficacy.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Related Concept Videos
Treatment Resistant Cancers
Transduction
Cell Specific Gene Expression
Targeted Cancer Therapies
There are several types of targeted therapies against...